1,311
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

An easy-to-use scoring system for predicting bacteraemia with third-generation cephalosporin-resistant Enterobacterales in a low-resistance setting

, & ORCID Icon
Pages 242-248 | Received 13 Jun 2019, Accepted 12 Dec 2019, Published online: 23 Dec 2019

References

  • Pitout JDD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8(3):159–166.
  • Folkhälsomyndigheten. Extended spectrum beta-lactamase (ESBL) – sjukdomsstatistik — Folkhälsomyndigheten [Internet]. Available from: https://www.folkhalsomyndigheten.se/folkhalsorapportering-statistik/statistikdatabaser-och-visualisering/sjukdomsstatistik/extended-spectrum-beta-lactamase-esbl
  • Van Aken S, Lund N, Ahl J, et al. Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum β-lactamase-producing Escherichia coli bacteraemia. Scand J Infect Dis. 2014;46(11):753–762.
  • Anesi JA, Lautenbach E, Nachamkin I, et al. Poor clinical outcomes associated with community-onset urinary tract infections due to extended-spectrum cephalosporin-resistant Enterobacteriaceae. Infect Control Hosp Epidemiol. 2018;39(12):1431–1435.
  • Rottier WC, van Werkhoven CH, Bamberg YRP, et al. Development of diagnostic prediction tools for bacteraemia caused by third-generation cephalosporin-resistant Enterobacteria in suspected bacterial infections: a nested case-control study. Clin Microbiol Infect. 2018;24(12):1315–1321.
  • MacFadden DR, Coburn B, Shah N, et al. Decision-support models for empiric antibiotic selection in Gram-negative bloodstream infections. Clin Microbiol Infect. 2019;25(1):108.e1–108.e7.
  • Fröding I, Valik JK, Bolinder L, et al. Prediction of bloodstream infection caused by extended-spectrum β-lactamase-producing Enterobacterales in patients with suspected community-onset sepsis. Int J Antimicrob Agents. 2019;53(6):820–829.
  • EUCAST. Antimicrobial susceptibility testing [Internet]. eucast.org [cited 2019 Dec 17]. Available from: http://www.eucast.org/ast_of_bacteria/
  • Brolund A. Overview of ESBL-producing Enterobacteriaceae from a Nordic perspective. Infect Ecol Epidemiol. 2014;4.
  • Lee C-C, Lee C-H, Hong M-Y, et al. Propensity-matched analysis of the impact of extended-spectrum β-lactamase production on adults with community-onset Escherichia coli, Klebsiella species, and Proteus mirabilis bacteremia. J Microbiol Immunol Infect. 2018;51(4):519–526.
  • Liu VX, Fielding-Singh V, Greene JD, et al. The timing of early antibiotics and hospital mortality in sepsis. Am J Respir Crit Care Med. 2017;196(7):856–863.
  • Falcone M, Tiseo G, Dentali F, et al. Predicting resistant etiology in hospitalized patients with blood cultures positive for Gram-negative bacilli. Eur J Intern Med. 2018;53:21–28.
  • Johnson SW, Anderson DJ, May DB, et al. Utility of a clinical risk factor scoring model in predicting infection with extended-spectrum β-lactamase-producing Enterobacteriaceae on hospital admission. Infect Control Hosp Epidemiol. 2013;34(4):385–392.
  • Tham J, Odenholt I, Walder M, et al. Risk factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli in a county of Southern Sweden. Infect Drug Resist. 2013;6:93–97.
  • Lee C-H, Chu F-Y, Hsieh C-C, et al. A simple scoring algorithm predicting extended-spectrum β-lactamase producers in adults with community-onset monomicrobial Enterobacteriaceae bacteremia: matters of frequent emergency department users. Medicine (Baltimore). 2017;96(16):e6648.
  • ECDC. Surveillance of antimicrobial resistance in Europe – annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2017. Stockholm; 2018.
  • Khawaja T, Kirveskari J, Johansson S, et al. Patients hospitalized abroad as importers of multiresistant bacteria—a cross-sectional study. Clin Microbiol Infect. 2017;23(9):673.e1–673.e8.
  • Isendahl J, Giske CG, Hammar U, et al. Temporal dynamics and risk factors for bloodstream infection with extended-spectrum β-lactamase-producing bacteria in previously-colonized individuals: National Population-based Cohort Study. Clin Infect Dis. 2019;68(4):641–649.
  • Rottier WC, Bamberg YRP, Dorigo-Zetsma JW, et al. Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant Enterobacteriaceae bacteremia in patients with sepsis. Clin Infect Dis. 2015;60:1622–1630.
  • Ny S, Löfmark S, Börjesson S, et al. Community carriage of ESBL-producing Escherichia coli is associated with strains of low pathogenicity: a Swedish nationwide study. J Antimicrob Chemother. 2017;72(2):582–588.
  • Lindblom A, Karami N, Magnusson T, et al. Subsequent infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with prior infection or fecal colonization. Eur J Clin Microbiol Infect Dis. 2018;37(8):1491–1497.
  • Denis B, Lafaurie M, Donay JL, et al. Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study. Int J Infect Dis. 2015;39:1–6.
  • Goodman KE, Lessler J, Cosgrove SE, et al. A clinical decision tree to predict whether a bacteremic patient is infected with an extended-spectrum β-lactamase-producing organism. Clin Infect Dis. 2016;63(7):896–903.
  • Augustine MR, Testerman TL, Justo JA, et al. Clinical risk score for prediction of extended-spectrum β-lactamase-producing Enterobacteriaceae in bloodstream isolates. Infect Control Hosp Epidemiol. 2017;38(3):266–272.
  • Isendahl J, Giske CG, Tegmark Wisell K, et al. Risk factors for community-onset bloodstream infection with extended-spectrum β-lactamase-producing Enterobacteriaceae: national population-based case-control study. Clin Microbiol Infect. 2019;25(11):1408–1414.
  • Sundvall P-D, Elm M, Gunnarsson R, et al. Antimicrobial resistance in urinary pathogens among Swedish nursing home residents remains low: a cross-sectional study comparing antimicrobial resistance from 2003 to 2012. BMC Geriatr. 2014;14(1):30.